Goto

Collaborating Authors

 pubmed abstract


MedPath: Multi-Domain Cross-Vocabulary Hierarchical Paths for Biomedical Entity Linking

arXiv.org Artificial Intelligence

Progress in biomedical Named Entity Recognition (NER) and Entity Linking (EL) is currently hindered by a fragmented data landscape, a lack of resources for building explainable models, and the limitations of semantically-blind evaluation metrics. To address these challenges, we present MedPath, a large-scale and multi-domain biomedical EL dataset that builds upon nine existing expert-annotated EL datasets. In MedPath, all entities are 1) normalized using the latest version of the Unified Medical Language System (UMLS), 2) augmented with mappings to 62 other biomedical vocabularies and, crucially, 3) enriched with full ontological paths -- i.e., from general to specific -- in up to 11 biomedical vocabularies. MedPath directly enables new research frontiers in biomedical NLP, facilitating training and evaluation of semantic-rich and interpretable EL systems, and the development of the next generation of interoperable and explainable clinical NLP models.


Decoding Plastic Toxicity: An Intelligent Framework for Conflict-Aware Relational Metapath Extraction from Scientific Abstracts

arXiv.org Artificial Intelligence

The widespread use of plastics and their persistence in the environment have led to the accumulation of micro- and nano-plastics across air, water, and soil, posing serious health risks including respiratory, gastrointestinal, and neurological disorders. We propose a novel framework that leverages large language models to extract relational metapaths, multi-hop semantic chains linking pollutant sources to health impacts, from scientific abstracts. Our system identifies and connects entities across diverse contexts to construct structured relational metapaths, which are aggregated into a Toxicity Trajectory Graph that traces pollutant propagation through exposure routes and biological systems. Moreover, to ensure consistency and reliability, we incorporate a dynamic evidence reconciliation module that resolves semantic conflicts arising from evolving or contradictory research findings. Our approach demonstrates strong performance in extracting reliable, high-utility relational knowledge from noisy scientific text and offers a scalable solution for mining complex cause-effect structures in domain-specific corpora.


Specialised or Generic? Tokenization Choices for Radiology Language Models

arXiv.org Artificial Intelligence

The vocabulary used by language models (LM) - defined by the tokenizer - plays a key role in text generation quality. However, its impact remains under-explored in radiology. In this work, we address this gap by systematically comparing general, medical, and domain-specific tokenizers on the task of radiology report summarisation across three imaging modalities. We also investigate scenarios with and without LM pre-training on PubMed abstracts. Our findings demonstrate that medical and domain-specific vocabularies outperformed widely used natural language alternatives when models are trained from scratch. Pre-training partially mitigates performance differences between tokenizers, whilst the domain-specific tokenizers achieve the most favourable results. Domain-specific tokenizers also reduce memory requirements due to smaller vocabularies and shorter sequences. These results demonstrate that adapting the vocabulary of LMs to the clinical domain provides practical benefits, including improved performance and reduced computational demands, making such models more accessible and effective for both research and real-world healthcare settings.


EvidenceOutcomes: a Dataset of Clinical Trial Publications with Clinically Meaningful Outcomes

arXiv.org Artificial Intelligence

The fundamental process of evidence extraction and synthesis in evidence-based medicine involves extracting PICO (Population, Intervention, Comparison, and Outcome) elements from biomedical literature. However, Outcomes, being the most complex elements, are often neglected or oversimplified in existing benchmarks. To address this issue, we present EvidenceOutcomes, a novel, large, annotated corpus of clinically meaningful outcomes extracted from biomedical literature. We first developed a robust annotation guideline for extracting clinically meaningful outcomes from text through iteration and discussion with clinicians and Natural Language Processing experts. Then, three independent annotators annotated the Results and Conclusions sections of a randomly selected sample of 500 PubMed abstracts and 140 PubMed abstracts from the existing EBM-NLP corpus. This resulted in EvidenceOutcomes with high-quality annotations of an inter-rater agreement of 0.76. Additionally, our fine-tuned PubMedBERT model, applied to these 500 PubMed abstracts, achieved an F1-score of 0.69 at the entity level and 0.76 at the token level on the subset of 140 PubMed abstracts from the EBM-NLP corpus. EvidenceOutcomes can serve as a shared benchmark to develop and test future machine learning algorithms to extract clinically meaningful outcomes from biomedical abstracts.


IHC-LLMiner: Automated extraction of tumour immunohistochemical profiles from PubMed abstracts using large language models

arXiv.org Artificial Intelligence

Immunohistochemistry (IHC) is essential in diagnostic pathology and biomedical research, offering critical insights into protein expression and tumour biology. This study presents an automated pipeline, IHC-LLMiner, for extracting IHC-tumour profiles from PubMed abstracts, leveraging advanced biomedical text mining. There are two subtasks: abstract classification (include/exclude as relevant) and IHC-tumour profile extraction on relevant included abstracts. The best-performing model, "Gemma-2 finetuned", achieved 91.5% accuracy and an F1 score of 91.4, outperforming GPT4-O by 9.5% accuracy with 5.9 times faster inference time. From an initial dataset of 107,759 abstracts identified for 50 immunohistochemical markers, the classification task identified 30,481 relevant abstracts (Include) using the Gemma-2 finetuned model. For IHC-tumour profile extraction, the Gemma-2 finetuned model achieved the best performance with 63.3% Correct outputs. Extracted IHC-tumour profiles (tumour types and markers) were normalised to Unified Medical Language System (UMLS) concepts to ensure consistency and facilitate IHC-tumour profile landscape analysis. The extracted IHC-tumour profiles demonstrated excellent concordance with available online summary data and provided considerable added value in terms of both missing IHC-tumour profiles and quantitative assessments. Our proposed LLM based pipeline provides a practical solution for large-scale IHC-tumour profile data mining, enhancing the accessibility and utility of such data for research and clinical applications as well as enabling the generation of quantitative and structured data to support cancer-specific knowledge base development. Models and training datasets are available at https://github.com/knowlab/IHC-LLMiner.


Gender-Neutral Large Language Models for Medical Applications: Reducing Bias in PubMed Abstracts

arXiv.org Artificial Intelligence

This paper presents a pipeline for mitigating gender bias in large language models (LLMs) used in medical literature by neutralizing gendered occupational pronouns. A dataset of 379,000 PubMed abstracts from 1965-1980 was processed to identify and modify pronouns tied to professions. We developed a BERT-based model, "Modern Occupational Bias Elimination with Refined Training," or "MOBERT," trained on these neutralized abstracts, and compared its performance with "1965Bert," trained on the original dataset. MOBERT achieved a 70% inclusive replacement rate, while 1965Bert reached only 4%. A further analysis of MOBERT revealed that pronoun replacement accuracy correlated with the frequency of occupational terms in the training data. We propose expanding the dataset and refining the pipeline to improve performance and ensure more equitable language modeling in medical applications. Introduction Background Large language models (LLMs) are now widely used for a range of applications, from creating customer service chatbots to advertising that targets specific clients to predicting financial outcomes from potential economic indicators. LLMs have also increased in presence in the medical sector, ranging from accessible diagnostics to comprehensive literature retrieval, where they hold the promise of leading to a more informed level of care. Given the critical nature of these uses, it is essential to ensure that such LLMs remain free from biases that could potentially impact patient treatment and outcomes.


ClusterTalk: Corpus Exploration Framework using Multi-Dimensional Exploratory Search

arXiv.org Artificial Intelligence

Exploratory search of large text corpora is essential in domains like biomedical research, where large amounts of research literature are continuously generated. This paper presents ClusterTalk (The demo video and source code are available at: https://github.com/achouhan93/ClusterTalk), a framework for corpus exploration using multi-dimensional exploratory search. Our system integrates document clustering with faceted search, allowing users to interactively refine their exploration and ask corpus and document-level queries. Compared to traditional one-dimensional search approaches like keyword search or clustering, this system improves the discoverability of information by encouraging a deeper interaction with the corpus. We demonstrate the functionality of the ClusterTalk framework based on four million PubMed abstracts for the four-year time frame.


Automatically Labeling $200B Life-Saving Datasets: A Large Clinical Trial Outcome Benchmark

arXiv.org Artificial Intelligence

The global cost of drug discovery and development exceeds $200 billion annually. The main results of drug discovery and development are the outcomes of clinical trials, which directly influence the regulatory approval of new drug candidates and ultimately affect patient outcomes. Despite their significance, large-scale, high-quality clinical trial outcome data are not readily available to the public. Suppose a large clinical trial outcome dataset is provided; machine learning researchers can potentially develop accurate prediction models using past trials and outcome labels, which could help prioritize and optimize therapeutic programs, ultimately benefiting patients. This paper introduces Clinical Trial Outcome (CTO) dataset, the largest trial outcome dataset with around 479K clinical trials, aggregating outcomes from multiple sources of weakly supervised labels, minimizing the noise from individual sources, and eliminating the need for human annotation. These sources include large language model (LLM) decisions on trial-related documents, news headline sentiments, stock prices of trial sponsors, trial linkages across phases, and other signals such as patient dropout rates and adverse events. CTO's labels show unprecedented agreement with supervised clinical trial outcome labels from test split of the supervised TOP dataset, with a 91 F1.


Predicting Drug-Gene Relations via Analogy Tasks with Word Embeddings

arXiv.org Artificial Intelligence

Natural language processing (NLP) is utilized in a wide range of fields, where words in text are typically transformed into feature vectors called embeddings. BioConceptVec is a specific example of embeddings tailored for biology, trained on approximately 30 million PubMed abstracts using models such as skip-gram. Generally, word embeddings are known to solve analogy tasks through simple vector arithmetic. For instance, $\mathrm{\textit{king}} - \mathrm{\textit{man}} + \mathrm{\textit{woman}}$ predicts $\mathrm{\textit{queen}}$. In this study, we demonstrate that BioConceptVec embeddings, along with our own embeddings trained on PubMed abstracts, contain information about drug-gene relations and can predict target genes from a given drug through analogy computations. We also show that categorizing drugs and genes using biological pathways improves performance. Furthermore, we illustrate that vectors derived from known relations in the past can predict unknown future relations in datasets divided by year.


EnzChemRED, a rich enzyme chemistry relation extraction dataset

arXiv.org Artificial Intelligence

Expert curation is essential to capture knowledge of enzyme functions from the scientific literature in FAIR open knowledgebases but cannot keep pace with the rate of new discoveries and new publications. In this work we present EnzChemRED, for Enzyme Chemistry Relation Extraction Dataset, a new training and benchmarking dataset to support the development of Natural Language Processing (NLP) methods such as (large) language models that can assist enzyme curation. EnzChemRED consists of 1,210 expert curated PubMed abstracts in which enzymes and the chemical reactions they catalyze are annotated using identifiers from the UniProt Knowledgebase (UniProtKB) and the ontology of Chemical Entities of Biological Interest (ChEBI). We show that fine-tuning pre-trained language models with EnzChemRED can significantly boost their ability to identify mentions of proteins and chemicals in text (Named Entity Recognition, or NER) and to extract the chemical conversions in which they participate (Relation Extraction, or RE), with average F1 score of 86.30% for NER, 86.66% for RE for chemical conversion pairs, and 83.79% for RE for chemical conversion pairs and linked enzymes. We combine the best performing methods after fine-tuning using EnzChemRED to create an end-to-end pipeline for knowledge extraction from text and apply this to abstracts at PubMed scale to create a draft map of enzyme functions in literature to guide curation efforts in UniProtKB and the reaction knowledgebase Rhea. The EnzChemRED corpus is freely available at https://ftp.expasy.org/databases/rhea/nlp/.